Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection
Author(s) -
Bailin Zhang,
Marc Fila,
May Fakhoury,
Véronique Baudouin,
Georges Deschênes,
Evelyne JacqzAigrain,
Wei Zhao
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - Norwegian
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt472
Subject(s) - ganciclovir , valganciclovir , cytomegalovirus , pharmacokinetics , medicine , nephrotic syndrome , betaherpesvirinae , pediatrics , virology , human cytomegalovirus , viral disease , herpesviridae , human immunodeficiency virus (hiv) , virus
Emergency Department, The Third Hospital of Hebei Medical University, Shijiazhuang, China; Department of Paediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Assistance Publique—Hôpitaux de Paris, Paris, France; Department of Paediatric Nephrology, Hôpital Robert Debré, Assistance Publique—Hôpitaux de Paris, Paris, France; University Paris Diderot, Press Sorbonne Paris Cité, Paris, France; Clinical Investigation Center CIC9202, INSERM, Paris, France
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom